• Return to Headlines

Akebia Therapeut (AKBA)

By David Diaz

SmarTrend identified a Downtrend for Akebia Therapeut (NASDAQ:AKBA) on September 30th, 2019 at $4.03. In approximately 2 months, Akebia Therapeut has returned 46.65% as of today's recent price of $5.91.

In the past 52 weeks, shares of Akebia Therapeut have traded between the current low of $0.00 and a high of $10.45 and are now at $0.00. Over the last five market days, the 200-day moving average (MA) has gone down 0.3% while the 50-day MA has advanced 3.2%.

Akebia Therapeutics, Inc. manufactures biopharmaceutical products. The Company develop and distributes novel therapeutics based on the biology of hypoxia inducible factor (HIF) for patients with kidney diseases. Akebia Therapeutics serves customers in the United States.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any changes in momentum for shares of Akebia Therapeut.

Log in and add Akebia Therapeut (AKBA) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights akebia therapeut

Ticker(s): AKBA